Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The human microbiota is an aggregate of microorganisms residing in the human body, mostly in the gastrointestinal tract. Human microbiome modulators are described as modulators that have the potential to modulate the microbiome to render beneficial effect on the human body.
The global human microbiome modulator market has maintained a stable annual growth rate of approximately 6.0% from 2015 to 2017. The market is expected to grow at a compound annual growth rate of 11.6% from 2018 to 2026.
Some government agencies around the world are already reorganizing their regulatory policies and regulations to expand access to advanced and cost-effective medical technologies to reduce economic, social and clinical burdens. Therefore, it is believed that the emergence of precision medical methods is expected to promote a paradigm shift in the healthcare industry. Human microbiome modulators are described as modulators that have the potential to modulate the microbiome to produce beneficial effects on the human body. With the advent of this field, precision care has been significantly enhanced to actually provide beneficial therapeutic effects.
Human Microbiome Modulators market report explains the definition, types, applications, major countries, and major players of the Human Microbiome Modulators market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Sanofi
Hansen Holding A / S
EI du Pont de Nemours
Probi AB
BioGaia AB
Bayer AG
Koninklijke DSM NV
Yakult Honsha Co，Ltd
Procter and Gamble Company
By Type:
Probiotics and Creams
Prebiotics and Dietary Supplements
Drugs
By End-User:
Digestive Health
Immune Health
Oral Health
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Human Microbiome Modulators Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Human Microbiome Modulators Outlook to 2028- Original Forecasts
-
2.2 Human Microbiome Modulators Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Human Microbiome Modulators Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Human Microbiome Modulators Market- Recent Developments
-
6.1 Human Microbiome Modulators Market News and Developments
-
6.2 Human Microbiome Modulators Market Deals Landscape
7 Human Microbiome Modulators Raw Materials and Cost Structure Analysis
-
7.1 Human Microbiome Modulators Key Raw Materials
-
7.2 Human Microbiome Modulators Price Trend of Key Raw Materials
-
7.3 Human Microbiome Modulators Key Suppliers of Raw Materials
-
7.4 Human Microbiome Modulators Market Concentration Rate of Raw Materials
-
7.5 Human Microbiome Modulators Cost Structure Analysis
-
7.5.1 Human Microbiome Modulators Raw Materials Analysis
-
7.5.2 Human Microbiome Modulators Labor Cost Analysis
-
7.5.3 Human Microbiome Modulators Manufacturing Expenses Analysis
8 Global Human Microbiome Modulators Import and Export Analysis (Top 10 Countries)
-
8.1 Global Human Microbiome Modulators Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Human Microbiome Modulators Export by Region (Top 10 Countries) (2017-2028)
9 Global Human Microbiome Modulators Market Outlook by Types and Applications to 2022
-
9.1 Global Human Microbiome Modulators Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Probiotics and Creams Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Prebiotics and Dietary Supplements Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Human Microbiome Modulators Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Digestive Health Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Immune Health Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Oral Health Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Human Microbiome Modulators Market Analysis and Outlook till 2022
-
10.1 Global Human Microbiome Modulators Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Human Microbiome Modulators Consumption (2017-2022)
-
10.2.2 Canada Human Microbiome Modulators Consumption (2017-2022)
-
10.2.3 Mexico Human Microbiome Modulators Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Human Microbiome Modulators Consumption (2017-2022)
-
10.3.2 UK Human Microbiome Modulators Consumption (2017-2022)
-
10.3.3 Spain Human Microbiome Modulators Consumption (2017-2022)
-
10.3.4 Belgium Human Microbiome Modulators Consumption (2017-2022)
-
10.3.5 France Human Microbiome Modulators Consumption (2017-2022)
-
10.3.6 Italy Human Microbiome Modulators Consumption (2017-2022)
-
10.3.7 Denmark Human Microbiome Modulators Consumption (2017-2022)
-
10.3.8 Finland Human Microbiome Modulators Consumption (2017-2022)
-
10.3.9 Norway Human Microbiome Modulators Consumption (2017-2022)
-
10.3.10 Sweden Human Microbiome Modulators Consumption (2017-2022)
-
10.3.11 Poland Human Microbiome Modulators Consumption (2017-2022)
-
10.3.12 Russia Human Microbiome Modulators Consumption (2017-2022)
-
10.3.13 Turkey Human Microbiome Modulators Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Human Microbiome Modulators Consumption (2017-2022)
-
10.4.2 Japan Human Microbiome Modulators Consumption (2017-2022)
-
10.4.3 India Human Microbiome Modulators Consumption (2017-2022)
-
10.4.4 South Korea Human Microbiome Modulators Consumption (2017-2022)
-
10.4.5 Pakistan Human Microbiome Modulators Consumption (2017-2022)
-
10.4.6 Bangladesh Human Microbiome Modulators Consumption (2017-2022)
-
10.4.7 Indonesia Human Microbiome Modulators Consumption (2017-2022)
-
10.4.8 Thailand Human Microbiome Modulators Consumption (2017-2022)
-
10.4.9 Singapore Human Microbiome Modulators Consumption (2017-2022)
-
10.4.10 Malaysia Human Microbiome Modulators Consumption (2017-2022)
-
10.4.11 Philippines Human Microbiome Modulators Consumption (2017-2022)
-
10.4.12 Vietnam Human Microbiome Modulators Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Human Microbiome Modulators Consumption (2017-2022)
-
10.5.2 Colombia Human Microbiome Modulators Consumption (2017-2022)
-
10.5.3 Chile Human Microbiome Modulators Consumption (2017-2022)
-
10.5.4 Argentina Human Microbiome Modulators Consumption (2017-2022)
-
10.5.5 Venezuela Human Microbiome Modulators Consumption (2017-2022)
-
10.5.6 Peru Human Microbiome Modulators Consumption (2017-2022)
-
10.5.7 Puerto Rico Human Microbiome Modulators Consumption (2017-2022)
-
10.5.8 Ecuador Human Microbiome Modulators Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Human Microbiome Modulators Consumption (2017-2022)
-
10.6.2 Kuwait Human Microbiome Modulators Consumption (2017-2022)
-
10.6.3 Oman Human Microbiome Modulators Consumption (2017-2022)
-
10.6.4 Qatar Human Microbiome Modulators Consumption (2017-2022)
-
10.6.5 Saudi Arabia Human Microbiome Modulators Consumption (2017-2022)
-
10.6.6 United Arab Emirates Human Microbiome Modulators Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Human Microbiome Modulators Consumption (2017-2022)
-
10.7.2 South Africa Human Microbiome Modulators Consumption (2017-2022)
-
10.7.3 Egypt Human Microbiome Modulators Consumption (2017-2022)
-
10.7.4 Algeria Human Microbiome Modulators Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Human Microbiome Modulators Consumption (2017-2022)
-
10.8.2 New Zealand Human Microbiome Modulators Consumption (2017-2022)
11 Global Human Microbiome Modulators Competitive Analysis
-
11.1 Sanofi
-
11.1.1 Sanofi Company Details
-
11.1.2 Sanofi Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Sanofi Human Microbiome Modulators Main Business and Markets Served
-
11.1.4 Sanofi Human Microbiome Modulators Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Hansen Holding A / S
-
11.2.1 Hansen Holding A / S Company Details
-
11.2.2 Hansen Holding A / S Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Hansen Holding A / S Human Microbiome Modulators Main Business and Markets Served
-
11.2.4 Hansen Holding A / S Human Microbiome Modulators Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 EI du Pont de Nemours
-
11.3.1 EI du Pont de Nemours Company Details
-
11.3.2 EI du Pont de Nemours Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 EI du Pont de Nemours Human Microbiome Modulators Main Business and Markets Served
-
11.3.4 EI du Pont de Nemours Human Microbiome Modulators Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Probi AB
-
11.4.1 Probi AB Company Details
-
11.4.2 Probi AB Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Probi AB Human Microbiome Modulators Main Business and Markets Served
-
11.4.4 Probi AB Human Microbiome Modulators Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 BioGaia AB
-
11.5.1 BioGaia AB Company Details
-
11.5.2 BioGaia AB Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 BioGaia AB Human Microbiome Modulators Main Business and Markets Served
-
11.5.4 BioGaia AB Human Microbiome Modulators Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Bayer AG
-
11.6.1 Bayer AG Company Details
-
11.6.2 Bayer AG Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Bayer AG Human Microbiome Modulators Main Business and Markets Served
-
11.6.4 Bayer AG Human Microbiome Modulators Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Koninklijke DSM NV
-
11.7.1 Koninklijke DSM NV Company Details
-
11.7.2 Koninklijke DSM NV Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Koninklijke DSM NV Human Microbiome Modulators Main Business and Markets Served
-
11.7.4 Koninklijke DSM NV Human Microbiome Modulators Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Yakult Honsha Co，Ltd
-
11.8.1 Yakult Honsha Co，Ltd Company Details
-
11.8.2 Yakult Honsha Co，Ltd Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Yakult Honsha Co，Ltd Human Microbiome Modulators Main Business and Markets Served
-
11.8.4 Yakult Honsha Co，Ltd Human Microbiome Modulators Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Procter and Gamble Company
-
11.9.1 Procter and Gamble Company Company Details
-
11.9.2 Procter and Gamble Company Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Procter and Gamble Company Human Microbiome Modulators Main Business and Markets Served
-
11.9.4 Procter and Gamble Company Human Microbiome Modulators Product Portfolio
-
11.9.5 Recent Research and Development Strategies
12 Global Human Microbiome Modulators Market Outlook by Types and Applications to 2028
-
12.1 Global Human Microbiome Modulators Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Probiotics and Creams Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Prebiotics and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Drugs Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Human Microbiome Modulators Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Digestive Health Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Immune Health Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Oral Health Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Human Microbiome Modulators Market Analysis and Outlook to 2028
-
13.1 Global Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.2.2 Canada Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.2.3 Mexico Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.3.2 UK Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.3.3 Spain Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.3.4 Belgium Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.3.5 France Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.3.6 Italy Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.3.7 Denmark Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.3.8 Finland Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.3.9 Norway Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.3.10 Sweden Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.3.11 Poland Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.3.12 Russia Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.3.13 Turkey Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.4.2 Japan Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.4.3 India Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.4.4 South Korea Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.4.8 Thailand Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.4.9 Singapore Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.4.11 Philippines Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.5.2 Colombia Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.5.3 Chile Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.5.4 Argentina Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.5.6 Peru Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.6.3 Oman Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.6.4 Qatar Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.7.2 South Africa Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.7.3 Egypt Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.7.4 Algeria Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Human Microbiome Modulators Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Human Microbiome Modulators Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Human Microbiome Modulators
-
Figure of Human Microbiome Modulators Picture
-
Table Global Human Microbiome Modulators Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Human Microbiome Modulators Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Probiotics and Creams Consumption and Growth Rate (2017-2022)
-
Figure Global Prebiotics and Dietary Supplements Consumption and Growth Rate (2017-2022)
-
Figure Global Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Digestive Health Consumption and Growth Rate (2017-2022)
-
Figure Global Immune Health Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Health Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Human Microbiome Modulators Consumption by Country (2017-2022)
-
Table North America Human Microbiome Modulators Consumption by Country (2017-2022)
-
Figure United States Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Canada Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Mexico Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Table Europe Human Microbiome Modulators Consumption by Country (2017-2022)
-
Figure Germany Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure UK Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Spain Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Belgium Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure France Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Italy Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Denmark Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Finland Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Norway Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Sweden Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Poland Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Russia Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Turkey Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Table APAC Human Microbiome Modulators Consumption by Country (2017-2022)
-
Figure China Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Japan Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure India Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure South Korea Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Thailand Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Singapore Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Philippines Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Table South America Human Microbiome Modulators Consumption by Country (2017-2022)
-
Figure Brazil Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Colombia Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Chile Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Argentina Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Peru Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Table GCC Human Microbiome Modulators Consumption by Country (2017-2022)
-
Figure Bahrain Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Oman Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Qatar Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Table Africa Human Microbiome Modulators Consumption by Country (2017-2022)
-
Figure Nigeria Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure South Africa Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Egypt Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure Algeria Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Table Oceania Human Microbiome Modulators Consumption by Country (2017-2022)
-
Figure Australia Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Human Microbiome Modulators Consumption and Growth Rate (2017-2022)
-
Table Sanofi Company Details
-
Table Sanofi Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Human Microbiome Modulators Main Business and Markets Served
-
Table Sanofi Human Microbiome Modulators Product Portfolio
-
Table Hansen Holding A / S Company Details
-
Table Hansen Holding A / S Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hansen Holding A / S Human Microbiome Modulators Main Business and Markets Served
-
Table Hansen Holding A / S Human Microbiome Modulators Product Portfolio
-
Table EI du Pont de Nemours Company Details
-
Table EI du Pont de Nemours Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table EI du Pont de Nemours Human Microbiome Modulators Main Business and Markets Served
-
Table EI du Pont de Nemours Human Microbiome Modulators Product Portfolio
-
Table Probi AB Company Details
-
Table Probi AB Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Probi AB Human Microbiome Modulators Main Business and Markets Served
-
Table Probi AB Human Microbiome Modulators Product Portfolio
-
Table BioGaia AB Company Details
-
Table BioGaia AB Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table BioGaia AB Human Microbiome Modulators Main Business and Markets Served
-
Table BioGaia AB Human Microbiome Modulators Product Portfolio
-
Table Bayer AG Company Details
-
Table Bayer AG Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Human Microbiome Modulators Main Business and Markets Served
-
Table Bayer AG Human Microbiome Modulators Product Portfolio
-
Table Koninklijke DSM NV Company Details
-
Table Koninklijke DSM NV Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Koninklijke DSM NV Human Microbiome Modulators Main Business and Markets Served
-
Table Koninklijke DSM NV Human Microbiome Modulators Product Portfolio
-
Table Yakult Honsha Co，Ltd Company Details
-
Table Yakult Honsha Co，Ltd Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Yakult Honsha Co，Ltd Human Microbiome Modulators Main Business and Markets Served
-
Table Yakult Honsha Co，Ltd Human Microbiome Modulators Product Portfolio
-
Table Procter and Gamble Company Company Details
-
Table Procter and Gamble Company Human Microbiome Modulators Sales, Price, Value and Gross Profit (2017-2022)
-
Table Procter and Gamble Company Human Microbiome Modulators Main Business and Markets Served
-
Table Procter and Gamble Company Human Microbiome Modulators Product Portfolio
-
Figure Global Probiotics and Creams Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prebiotics and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Digestive Health Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immune Health Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Health Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Human Microbiome Modulators Consumption Forecast by Country (2022-2028)
-
Table North America Human Microbiome Modulators Consumption Forecast by Country (2022-2028)
-
Figure United States Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Human Microbiome Modulators Consumption Forecast by Country (2022-2028)
-
Figure Germany Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Human Microbiome Modulators Consumption Forecast by Country (2022-2028)
-
Figure China Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Human Microbiome Modulators Consumption Forecast by Country (2022-2028)
-
Figure Brazil Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Human Microbiome Modulators Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Human Microbiome Modulators Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Human Microbiome Modulators Consumption Forecast by Country (2022-2028)
-
Figure Australia Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Human Microbiome Modulators Consumption Forecast and Growth Rate (2022-2028)
-
